hrp 102 has been researched along with Cancer of the Uterus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| A R, S; Al Hendy, A; Ali, M | 1 |
1 review(s) available for hrp 102 and Cancer of the Uterus
| Article | Year |
|---|---|
Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Topics: Animals; Drug Combinations; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocarbons, Fluorinated; Leiomyoma; Menorrhagia; Norethindrone; Premenopause; Pyrimidines; Uterine Neoplasms | 2021 |